Psychiatry · Epidemiology · Clinical informatics
Psychiatrist and clinical researcher
Assistant Professor of Clinical Psychiatry, Columbia University Irving Medical Center. My research examines psychiatric treatment, substance use, and mental health outcomes in adolescents and young adults. I combine epidemiology and clinical informatics with clinical work across the lifespan.
For researchers and clinicians
My work examines psychiatric treatment, substance use, and the use of clinical information to improve care.
For patients & families
Adults, adolescents, and children seen in Manhattan. Evaluations that distinguish ADHD from what commonly imitates it.
Selected work
Selected findings and commentary, with links to the publications and study context.
In a national adolescent sample, ADHD was associated with markedly elevated odds of suicide attempts (aOR 2.9), school expulsion (aOR 3.3), and substance use (cannabis aOR 2.2, cocaine aOR 2.6).
My coauthors and I discuss registry evidence on ADHD medication and outcomes beyond symptom ratings, including how associations may change as treatment reaches a broader population.
Among 187,563 commercially insured youths newly diagnosed with ADHD, 2.6% received an antipsychotic within a year. Of those, 47.9% had no stimulant prescription between the new ADHD diagnosis and antipsychotic initiation.
Research program
Clinical evidence reviews
Reviews of centanafadine trial design, effect estimates, prescribing information, and the limitations of comparisons across studies.
Recent analyses, newest first. Full archive on the blog.
— Centanafadine: A Deep Analysis of the Primary Literature
A review of trial design, effect estimates, dose comparisons, and limitations.
— Centanafadine (Simtriyo): What the Label Actually Says
A guide to prescribing information and its clinical interpretation.
— Centanafadine Primary Literature Archive
Primary publications with citations and notes on interpreting trial reports.
— ADHD Coaching: What the Evidence Actually Shows
A review of coaching research, study limitations, and clinical considerations.
— ADHD medication and substance use: interpreting the evidence
Research on ADHD medication and substance use, with attention to study design and interpretation.
— The New ADHD Medications of 2024–2026
An overview of ADHD medication developments and their clinical context.
Areas of special focus: adverse outcomes of untreated ADHD · ADHD pharmacology & natural course
Reference
Seventy-plus pages written and maintained by a practicing academic psychiatrist, organized the way the questions actually arrive. Browse the full hub →
Manhattan practice
Free · roughly monthly
Notes on new ADHD research and medication developments, with links to primary publications and discussion of study limitations.
Unsubscribe any time. No clinical advice by email.
Common questions
My research examines psychiatric treatment, substance use, and youth mental health, using epidemiology and clinical informatics. Read about the research program.
I am an Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center and direct the Sultan Lab for Mental Health Informatics. View my Columbia faculty profile.
The publications page includes original research and invited commentary with links to source records. My curriculum vitae summarizes training and professional experience.
Use the research contact information for academic collaboration, speaking, or training inquiries.
I provide psychiatric care for children, adolescents, and adults in New York City. See the clinical practice page and ADHD evaluation information.
Request a consultation through Integrative Psych. The practice can confirm current availability, fees, and appointment format.
About
Double board-certified in adult and child & adolescent psychiatry. Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center. Director of the Sultan Lab for Mental Health Informatics. Clinical practice at Integrative Psych in Chelsea.